Novel protein kinase C inhibitors:: Synthesis and PKC inhibition of β-substituted polythiophene derivatives

被引：26
|
作者：
Xu, WC
Zhou, Q
Ashendel, CL
Chang, CT
Chang, CJ [1 ]
机构：
[1] Purdue Univ, Sch Pharm, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA
[2] Union Chem Labs, Hsinchu, Taiwan
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1999年 / 9卷 / 15期
关键词：
D O I：
10.1016/S0960-894X(99)00375-3
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
A series of beta-substituted polythiophene derivatives was synthesized through palladium-catalyzed coupling reaction. Their structure-protein kinase C (PKC) inhibitory activity relationship was studied. The carboxaldehyde and hydroxymethyl derivatives of alpha-terthiophene were potent PKC inhibitors (IC50 = 10(-7) M). (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码：2279 / 2282
页数：4
相关论文
共 50 条
  • [41] Discovery of substituted pyrazol-4-yl pyridazinone derivatives as novel c-Met kinase inhibitors
    Eun-Young Kim
    Seung-Tae Kang
    Heejung Jung
    Chi Hoon Park
    Chang-Soo Yun
    Jong Yeon Hwang
    Byung Jin Byun
    Chong Ock Lee
    Hyoung Rae Kim
    Jae Du Ha
    Do Hyun Ryu
    Sung Yun Cho
    Archives of Pharmacal Research, 2016, 39 : 453 - 464
  • [42] Discovery of substituted pyrazol-4-yl pyridazinone derivatives as novel c-Met kinase inhibitors
    Kim, Eun-Young
    Kang, Seung-Tae
    Jung, Heejung
    Park, Chi Hoon
    Yun, Chang-Soo
    Hwang, Jong Yeon
    Byun, Byung Jin
    Lee, Chong Ock
    Kim, Hyoung Rae
    Ha, Jae Du
    Ryu, Do Hyun
    Cho, Sung Yun
    ARCHIVES OF PHARMACAL RESEARCH, 2016, 39 (04) : 453 - 464
  • [43] SYNTHESIS AND EVALUATION OF SUBSTITUTED FLAVONES AS INHIBITORS OF TYROSINE PROTEIN-KINASE
    CUNNINGHAM, BDM
    THREADGILL, MD
    HICKMAN, JA
    BRITISH JOURNAL OF CANCER, 1987, 56 (02) : 207 - 207
  • [44] Protein kinase C in the developing kidney: Isoform expression and effects of ceramide and PKC inhibitors
    Serlachius, E
    Svennilson, J
    Schalling, M
    Aperia, A
    KIDNEY INTERNATIONAL, 1997, 52 (04) : 901 - 910
  • [45] Design and Optimization of Selective Protein Kinase C θ (PKCθ) Inhibitors for the Treatment of Autoimmune Diseases
    Jimenez, Juan-Miguel
    Boyall, Dean
    Brenchley, Guy
    Collier, Philip N.
    Davis, Christopher J.
    Fraysse, Damien
    Keily, Shazia B.
    Henderson, Jaclyn
    Miller, Andrew
    Pierard, Francoise
    Settimo, Luca
    Twin, Heather C.
    Bolton, Claire M.
    Curnock, Adam P.
    Chiu, Peter
    Tanner, Adam J.
    Young, Stephen
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (05) : 1799 - 1810
  • [46] Inhibition of protein kinase C mu by various inhibitors. Differentiation from protein kinase c isoenzymes
    Gschwendt, M
    Dieterich, S
    Rennecke, J
    Kittstein, W
    Mueller, HJ
    Johannes, FJ
    FEBS LETTERS, 1996, 392 (02): : 77 - 80
  • [47] A PLASMID ENCODING THE PSEUDOSUBSTRATE (PS) OF PROTEIN-KINASE-C (PKC) CAUSES PKC INHIBITION IN-VIVO
    TOWER, R
    WEISS, RH
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 816 - 816
  • [48] Synthesis, cytotoxicity and protein kinase C inhibition of arylpyrrolylmaleimides
    Xu, Gui-Qing
    Zhang, Chong
    Zhang, Lei
    Zhou, Xing-Lu
    Yang, Bo
    He, Qiao-Jun
    Hu, Yong-Zhou
    ARCHIV DER PHARMAZIE, 2008, 341 (05) : 273 - 280
  • [49] INHIBITION OF PROTEIN-KINASE-C (PKC) BY DRUGS PRODUCING MULTIDRUG RESISTANCE (MDR)
    HAIT, WN
    PALAYOOR, ST
    STEIN, JM
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 299 - 299
  • [50] Inhibition of the proteasome converts bryostatin from an antagonist to an agonist of protein kinase C (PKC).
    Smith, L
    Lee, HW
    Smith, JB
    FASEB JOURNAL, 1997, 11 (09): : A987 - A987
12345